Comments
Loading...
Immutep (NASDAQ:IMMP) Stock Quotes, Forecast and News Summary
Immutep Stock (NASDAQ: IMMP) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Immutep (IMMP) stock?
You can purchase shares of Immutep (NASDAQ:IMMP) through any online brokerage.
Who are Immutep (IMMP) competitors?
Other companies in Immutep’s space includes: 4D Molecular Therapeutics (NASDAQ:FDMT), Voyager Therapeutics (NASDAQ:VYGR), Sage Therapeutics (NASDAQ:SAGE), Tango Therapeutics (NASDAQ:TNGX) and aTyr Pharma (NASDAQ:ATYR).
What is the forecast, or price target, for Immutep (IMMP) stock?
Immutep has a consensus price target of $9.00.
What is the current price for Immutep (IMMP)?
The stock price for Immutep (NASDAQ: IMMP) is $2.02 last updated December 26, 2024 at 11:44 AM EST.
Does Immutep (IMMP) pay a dividend?
There are no upcoming dividends for Immutep.
When is Immutep (NASDAQ:IMMP) reporting earnings?
Immutep’s H1 earnings are confirmed for Thursday, February 27, 2025.
Is Immutep (IMMP) going to split?
There is no upcoming split for Immutep.
What sector and industry does Immutep (IMMP) operate in?
Immutep is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.